Advancing Knowledge. Supporting Better Care.
Explore significant clinical research, regulatory developments, and scientific advances shaping healthcare around the world.
Our Global Research platform provides healthcare professionals with concise, source-based summaries of important developments across key therapeutic areas.
The FDA has approved a palbociclib-based combination maintenance regimen for certain adults with HR-positive, HER2-positive locally advanced or metastatic breast cancer.
Read Overview →A new FDA approval expands maintenance-treatment options for selected adults with HR-positive, HER2-positive advanced breast cancer.
Read Overview →The Global Research section contains summaries of publicly available scientific and regulatory information from recognised international sources.
Unless specifically stated, the research featured in this section has not been conducted, sponsored, or funded by Platinum Pharma.
